These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7944027)

  • 1. Clinical efficacy and toxicity of doxorubicin encapsulated in glutaraldehyde-treated erythrocytes administered to dogs with lymphosarcoma.
    Matherne CM; Satterfield WC; Gasparini A; Tonetti M; Astroff AB; Schmidt RD; Rowe LD; DeLoach JR
    Am J Vet Res; 1994 Jun; 55(6):847-53. PubMed ID: 7944027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic properties of doxorubicin encapsulated in glutaraldehyde-treated canine erythrocytes.
    Tonetti M; Astroff AB; Satterfield W; De Flora A; Benatti U; DeLoach JR
    Am J Vet Res; 1991 Oct; 52(10):1630-5. PubMed ID: 1767983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Weekly administration of low-dose doxorubicin for treatment of malignant lymphoma in dogs.
    Ogilvie GK; Vail DM; Klein MK; Powers BE; Dickinson K
    J Am Vet Med Assoc; 1991 May; 198(10):1762-4. PubMed ID: 2071476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of pyridoxine to ameliorate the cutaneous toxicity associated with doxorubicin containing pegylated (Stealth) liposomes: a randomized, double-blind clinical trial using a canine model.
    Vail DM; Chun R; Thamm DH; Garrett LD; Cooley AJ; Obradovich JE
    Clin Cancer Res; 1998 Jun; 4(6):1567-71. PubMed ID: 9626479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of doxorubicin loaded and glutaraldehyde treated erythrocytes in healthy and lymphoma bearing dogs.
    Gasparini A; Tonetti M; Astroff B; Rowe L; Satterfield W; Schmidt R; DeLoach JR
    Adv Exp Med Biol; 1992; 326():299-304. PubMed ID: 1295317
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of body surface area-based and weight-based dosage protocols for doxorubicin administration in dogs.
    Arrington KA; Legendre AM; Tabeling GS; Frazier DL
    Am J Vet Res; 1994 Nov; 55(11):1587-92. PubMed ID: 7879983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doxorubicin for treatment of canine lymphosarcoma after development of resistance to combination chemotherapy.
    Calvert CA; Leifer CE
    J Am Vet Med Assoc; 1981 Nov; 179(10):1011-2. PubMed ID: 6896200
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of the effects of asparaginase administered subcutaneously versus intramuscularly for treatment of multicentric lymphoma in dogs receiving doxorubicin.
    Valerius KD; Ogilvie GK; Fettman MJ; Walton JA; Richardson K; Powers BE; McNiel EA; Rogers QR
    J Am Vet Med Assoc; 1999 Feb; 214(3):353-6. PubMed ID: 10023395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemoimmunotherapy for canine lymphosarcoma.
    Theilen GH; Worley M; Benjamini E
    J Am Vet Med Assoc; 1977 Mar; 170(6):607-10. PubMed ID: 576595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized controlled trial of doxorubicin versus dactinomycin in a multiagent protocol for treatment of dogs with malignant lymphoma.
    Khanna C; Lund EM; Redic KA; Hayden DW; Bell FW; Goulland EL; Klausner JS
    J Am Vet Med Assoc; 1998 Oct; 213(7):985-90. PubMed ID: 9776993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction and characterization of adriamycin-loaded canine red blood cells as a potential slow delivery system.
    Tonetti M; Astroff B; Satterfield W; De Flora A; Benatti U; DeLoach JR
    Biotechnol Appl Biochem; 1990 Dec; 12(6):621-9. PubMed ID: 2128736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of chronic doxorubicin cardiotoxicity in beagles by liposomal encapsulation.
    Herman EH; Rahman A; Ferrans VJ; Vick JA; Schein PS
    Cancer Res; 1983 Nov; 43(11):5427-32. PubMed ID: 6616474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II evaluation of doxorubicin for treatment of various canine neoplasms.
    Ogilvie GK; Reynolds HA; Richardson RC; Withrow SJ; Norris AM; Henderson RA; Klausner JS; Fowler JD; McCaw D
    J Am Vet Med Assoc; 1989 Dec; 195(11):1580-3. PubMed ID: 2599941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unexpected toxicity associated with use of body surface area for dosing melphalan in the dog.
    Page RL; Macy DW; Thrall DE; Dewhirst MW; Allen SL; Heidner GL; Sim DA; McGee ML; Gillette EL
    Cancer Res; 1988 Jan; 48(2):288-90. PubMed ID: 3335006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo liver and lung targeting of adriamycin encapsulated in glutaraldehyde-treated murine erythrocytes.
    Zocchi E; Tonetti M; Polvani C; Guida L; Benatti U; De Flora A
    Biotechnol Appl Biochem; 1988 Dec; 10(6):555-62. PubMed ID: 3148305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initial clinical (phase I) trial of TLC D-99 (doxorubicin encapsulated in liposomes).
    Cowens JW; Creaven PJ; Greco WR; Brenner DE; Tung Y; Ostro M; Pilkiewicz F; Ginsberg R; Petrelli N
    Cancer Res; 1993 Jun; 53(12):2796-802. PubMed ID: 8504422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ECG of the month. Doxorubicin cardiotoxicosis.
    Fowler MM; Jesty SA; Gompf RE; Johns SM
    J Am Vet Med Assoc; 2013 Jul; 243(1):52-4. PubMed ID: 23786190
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy and toxicity of doxorubicin/cyclophosphamide maintenance therapy in dogs with multicentric lymphosarcoma.
    Price GS; Page RL; Fischer BM; Levine JF; Gerig TM
    J Vet Intern Med; 1991; 5(5):259-62. PubMed ID: 1748977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute and short-term toxicoses associated with the administration of doxorubicin to dogs with malignant tumors.
    Ogilvie GK; Richardson RC; Curtis CR; Withrow SJ; Reynolds HA; Norris AM; Henderson RA; Klausner JS; Fowler JD; McCaw D
    J Am Vet Med Assoc; 1989 Dec; 195(11):1584-7. PubMed ID: 2599942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liposomal doxorubicin (Caelyx) in advanced pretreated soft tissue sarcomas: a phase II study of the Italian Sarcoma Group (ISG).
    Toma S; Tucci A; Villani G; Carteni G; Spadini N; Palumbo R
    Anticancer Res; 2000; 20(1B):485-91. PubMed ID: 10769710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.